VanEck Biotech ETF (NQ:BBH)

240.47 +6.43 (+2.75%)

Official Closing Price Updated: 4:15 PM EDT, Oct 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about VanEck Biotech ETF

< Previous 1 2 Next >

Economic Hurricane Ahead? 7 Profitable Places to Hide Your Money ↗

June 22, 2022

With an economic hurricane on the horizon, investors are searching for alternative investment paths and profitable places to invest in.

Via InvestorPlace

Progenity Is Unlikely to Live Up to Its IPO Hype ↗

December 15, 2021

Progenity went public in June 2020. Eighteen months later, PROG stock has lost 83% of its value. Is there any hope for this fading biotech?

Via InvestorPlace

How Are Biotech ETFs Reacting To These Q3 Earnings Releases? ↗

November 06, 2021

There's no denying that the pandemic has opened up investment opportunities in the biotech sector by triggering a race to introduce vaccines. Let’s take a look at big biotech earnings releases to see...

Via Talk Markets

Novavax Stock Is a Buy for Long-Term Investors on Its Pipeline Alone ↗

November 01, 2021

After the formidable run, NVAX stock has come under significant pressure, but between its pipeline and its Covid vaccine, it is a dip buy.

Via InvestorPlace

Take A Look At The Top-Performing Biotech ETFs YTD ↗

October 02, 2021

The biotechnology sector has been grabbing the headlines on the new coronavirus vaccine and drug-related updates. The space has also kept its promise of generating returns, with the Nasdaq...

Via Talk Markets

Biotech ETFs To Benefit From Latest Booster Update ↗

August 21, 2021

Vaccine makers like Moderna and Pfizer have reasons to cheer the update with regard to the application of boosters. The U.S. government announced plans to make COVID-19 vaccine boosters available from...

Via Talk Markets

ETF Investing Areas to Consider for August ↗

August 09, 2021

There is no doubt that the second-quarter 2021 earnings season is going strong.

Via Talk Markets

Moderna ETFs To Rise On Positive COVID-19 Vaccine Updates ↗

July 03, 2021

The competition to come up with a vaccine is opening up near-term opportunities, making the biotech sector a prospective space for investments. Therefore, we discuss a few ETFs that provide exposure to...

Via Talk Markets

5 Top ETFs With Exposure To Biogen ↗

June 07, 2021

Here is a look at five ETFs with large exposure to Biogen shares.

Via Talk Markets

5 Top ETFs With Exposure To Biogen ↗

June 07, 2021

For the first time in 18 years, there was a new treatment for Alzheimer’s Disease approved by the FDA. Aducanumab from Biogen Inc (NASDAQ: BIIB) was approved as a drug that...

Via Benzinga

Biotech ETFs To Suffer As US Backs IP Waiver For COVID-19 Vaccines ↗

May 08, 2021

The Biden administration announced support for the waiver of intellectual property protections for COVID-19 vaccines proposed by South Africa and India. Let’s take a look at ETFs that can suffer from...

Via Talk Markets

Topics Intellectual Property

Moderna Stock Moves After Q1 Print: Technical Levels For The COVID-19 Vaccine Play ↗

May 06, 2021

Moderna Inc. (NASDAQ: MRNA) shares gapped down Thursday and have since gained back some ground. Moderna reported first-quarter earnings Thursday of $2.84 per share, beating the...

Via Benzinga

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.